Recombinant human serum albumin-interferon α2b infusion protein (Wolwo Biotech)
白蛋白融合干扰素α-2b（浙江我武）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human serum albumin-interferon α2b infusion protein (Wolwo Biotech)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesZhejiang Wolwo Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesZhejiang Deqing Anping Bio-Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A